CTLA4 and Carcinoma, Lewis Lung: The peptides were also experimentally tested by means of bio-layer interferometry to confirm their ability to bind CTLA4 and by in vitro and in vivo experiments in Lewis lung carcinoma (LLC) cells and in orthotropic Lewis lung carcinoma allograft models to verify their capacity to block tumor cell growth.